Mixed model with correction for case-control ascertainment increases association power

Tristan J Hayeck1, Noah A Zaitlen2, Po-Ru Loh3

  • 1Department of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.

Insights

We developed a new statistical method, the liability-threshold mixed linear model (LTMLM), for genetic association studies. This approach improves power for low-prevalence diseases in case-control studies, outperforming existing methods.

Area of Science:

  • Genetics
  • Biostatistics
  • Epidemiology

Background:

  • Mixed-model methods are standard for genetic association studies.
  • Existing methods lose power in case-control studies, especially for low-prevalence diseases.
  • No prior solution addressed this power loss.

Purpose of the Study:

  • Introduce a novel association statistic, the liability-threshold mixed linear model (LTMLM).
  • Demonstrate LTMLM's improved power and controlled false-positive rates for low-prevalence diseases.
  • Address the power deficit of current methods in case-control genetic studies.

Main Methods:

  • Developed a χ(2) score statistic using posterior mean liabilities (PMLs) within the liability-threshold model.
  • Estimated individual PMLs considering case-control status and the genetic relationship matrix (GRM).
  • Utilized a multivariate Gibbs sampler for PML estimation and Haseman-Elston regression for heritability.

Main Results:

  • LTMLM exhibited a well-controlled false-positive rate in simulations.
  • LTMLM demonstrated superior power compared to existing mixed-model methods for low-prevalence diseases.
  • A real-world dataset (Wellcome Trust Case Control Consortium 2) showed a 4.3% improvement in χ(2) statistics with LTMLM.

Conclusions:

  • LTMLM offers a significant advancement for genetic association studies in case-control designs.
  • The method is particularly beneficial for diseases with low prevalence, enhancing statistical power.
  • Future applications with larger sample sizes are expected to yield even greater power increases.

Related Concept Videos

Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
575
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
1.1K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.7K
Odds Ratio01:09

Odds Ratio

The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
2.4K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
720
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
737